Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

9.25

+0.04 (0.43%)

At close: Dec 5, 2025, 4:00 PM EST

9.38

+0.13 (1.41%)

After-hours: Dec 5, 2025, 7:56 PM EST

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020
Cell Engineering Revenue	141.53M	173.97M	Log In	Log In	Log In	Upgrade
Biosecurity Product Revenue	-	-	Log In	Log In	Log In	Upgrade
Biosecurity Service Revenue	39.07M	53.07M	Log In	Log In	Log In	Upgrade
Total Biosecurity Revenue	39.07M	53.07M	Log In	Log In	Log In	Upgrade
Revenue (Total)	180.61M	227.04M	Log In	Log In	Log In	Upgrade

EBIT

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020
Cell Engineering Operating Income	-75.13M	-218.57M	Log In	Log In	Log In	Upgrade
Biosecurity Operating Income	-24.63M	-30.62M	Log In	Log In	Log In	Upgrade
Corporate Operating Income	-	-310.57M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-209.83M	-	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-309.58M	-559.76M	Log In	Log In	Log In	Upgrade

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2019
New Programs	52.00	Log In	Log In	Log In	Upgrade
Current Active Programs	176.00	Log In	Log In	Log In	Upgrade
Cumulative Programs	294.00	Log In	Log In	Log In	Upgrade